Breaking News, Financial News

Financial Report: Draxis

Draxis Health

1Q Revenues: $21 million (+10%)

1Q Earnings: $2 million (+19%)

Comments: Contract manufacturing revenues for 1Q2007 were $14.2 million (+5%), due to new product introduction activities. The result was weaker compared to the fourth quarter of 2006 due in part to a delay in receiving components for Hectorol production, which resulted in reduced volumes manufactured during the quarter. Sterile products represented approximately 78% of manufacturing revenues compared to 81% for 1Q2006.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters